Ignite Creation Date:
2024-05-05 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00562068
Status:
UNKNOWN
Last Update Posted:
2013-08-26
First Post:
2007-11-20
Brief Title:
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I Stage II Stage III or Stage IV Peripheral T-Cell Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI